Estimated Read Time:

1 minute

SABCS Snippets: Results of the Phase II SUMIT-BC Trial

Saba Shaikh, MD, talks with Sonia Pernas, MD, PhD, about the results of the Phase II SUMIT-BC trial, which showed that the CDK7 inhibitor samuraciclib combined with fulvestrant demonstrated promising efficacy in ER+/HER2- locally advanced or metastatic breast cancer patients previously treated using an aromatase inhibitor with a CDK4/6 inhibitor.

Share

Recent Posts